v3.26.1
Segment Information (Details)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
USD ($)
Jun. 30, 2025
USD ($)
Jun. 30, 2026
USD ($)
segment
Jun. 30, 2025
USD ($)
Segment Reporting [Abstract]        
Number of operating segments | segment     1  
Number of reportable segments | segment     1  
Segment Reporting [Line Items]        
Total research and development expenses $ 61,766 $ 50,614 $ 127,357 $ 111,343
Total selling, general, and administrative expenses 72,872 71,038 137,942 134,460
Reportable Segment        
Segment Reporting [Line Items]        
Personnel compensation and related costs 22,713 22,447 41,183 46,527
Licensing fees 15,000 0 37,000 19,997
CROs/CMOs/Investigators expenses 18,259 19,935 37,800 29,765
Other costs 5,794 8,232 11,374 15,054
Total research and development expenses 61,766 50,614 127,357 111,343
Clinical programs 14,792 16,967 45,881 45,059
Pre-Clinical programs 19,609 5,069 31,325 8,383
Unallocated research and development expenses 27,365 28,578 50,151 57,901
Personnel compensation and related costs 44,707 42,679 85,767 83,322
Other costs 28,165 28,359 52,175 51,138
Total selling, general, and administrative expenses 72,872 71,038 137,942 134,460
Selling and marketing expenses 51,556 46,764 94,994 88,703
General and administrative expenses $ 21,316 $ 24,274 $ 42,948 $ 45,757